4 min read

EverHint – Momentum Swing Pack – Top 14 Signals for Sep 29, 2026

14 signals. Healthcare leads (10). price range $10-$186. 1 with insider selling.

Excerpt: 14 signals. Healthcare leads (10). price range $10-$186. 1 with insider selling.

Market Context

Equity markets are experiencing a mild pullback across all three major indices, with the Dow Jones leading losses at -0.26% and the Nasdaq showing relative resilience at just -0.09%. This modest divergence suggests large-cap growth is holding up better than value-oriented names, which is a nuanced but meaningful signal for risk appetite. With the VIX sitting at 16.04 — essentially flat and well within the "calm" range — there is no elevated fear premium in the market, meaning intraday swings are likely to remain contained and trending moves have a cleaner backdrop to develop.

The low volatility environment is a double-edged sword for today's signal mix. On one hand, strategies like Breakout Standard and Breakout Ultra Tight benefit from reduced noise, as price action near key levels is less likely to be whipsawed by volatility spikes. On the other hand, Volatile High Beta signals may see muted follow-through given the compressed VIX, since the momentum fuel that drives high-beta names tends to diminish in quieter tape conditions. Quality Low Vol and Large Cap Only strategies are well-suited to this environment, as investors appear to be favoring stability over speculation in a slightly risk-off session.

Healthcare's emergence as the top sector, generating the most signals today, aligns with a classic defensive rotation pattern often seen when markets drift lower without a clear directional catalyst. With all three indices in the red but losses shallow, capital appears to be rotating toward defensive sectors rather than fleeing equities outright. This positioning favors the Sector Healthcare signals and supports a selective, stock-specific approach rather than broad market momentum plays. Traders should be attentive to how the session develops into the close, as end-of-month positioning on September 29th could introduce incremental volatility not fully reflected in the current VIX reading.

Sector Healthcare

High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.

Entry Criteria:

  • Strong RSI momentum (configurable thresholds)
  • Volume surge above average
  • Price momentum confirmation
  • Minimum ADV: $25M+ (varies by variant)
  • Earnings buffer: 7 days pre/post earnings
  • Variant-specific filters applied

Holding period: 1-4 weeks | Risk level: Medium-High

📊 Signals (2 of 2)

Ranked by composite momentum score (higher = stronger momentum)

# Ticker Company Sector Price Score Insider MCap
1 GMAB Genmab A/S Healthcare $35.57 1.00 — $21.8B
2 ITGR Integer Holdings Corpo... Healthcare $126.33 0.00 — $4.3B

Volatile High Beta

High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.

Entry Criteria:

  • Strong RSI momentum (configurable thresholds)
  • Volume surge above average
  • Price momentum confirmation
  • Minimum ADV: $25M+ (varies by variant)
  • Earnings buffer: 7 days pre/post earnings
  • Variant-specific filters applied

Holding period: 1-4 weeks | Risk level: Medium-High

📊 Signals (3 of 3)

Ranked by composite momentum score (higher = stronger momentum)

# Ticker Company Sector Price Score Insider MCap
1 TWST Twist Bioscience Corpo... Healthcare $186.13 1.00 Sell -$15,322 $11.6B
2 IOVA Iovance Biotherapeutic... Healthcare $14.45 0.50 — $6.5B
3 ABCL AbCellera Biologics Inc. Healthcare $14.82 0.00 — $4.5B

Insider selling (7d): TWST (-$15,322)

Breakout Standard

Stocks within 3% of 52-week high - standard breakout momentum setups. Stock showing strong momentum near or at highs. Increased volume confirms institutional interest. Breaking out or consolidating near resistance.

Entry Criteria:

  • Strong RSI momentum
  • Volume surge above average
  • Within 3% of 52-week high
  • Minimum ADV: $25M+
  • Earnings buffer: 7 days

Holding period: 1-4 weeks | Risk level: Medium-High

📊 Signals (4 of 4)

Ranked by composite momentum score

# Ticker Company Sector Price Score Insider MCap
1 GMAB Genmab A/S Healthcare $35.57 0.90 — $21.8B
2 TBBB BBB Foods Inc. Consumer Defensive $52.40 0.53 — $6.1B
3 MGNI Magnite, Inc. Communication Services $25.67 0.33 — $3.7B
4 ITGR Integer Holdings Corpo... Healthcare $126.33 0.00 — $4.3B

Pullback Standard

Standard pullback setup - stocks that dipped below MA21 and reclaimed it. Indicates potential bounce/continuation after healthy pullback. Lower-risk entries in established uptrends.

Entry Criteria:

  • Dipped below MA21
  • Reclaimed MA21 on increased volume
  • Volume surge above average
  • Minimum ADV: $25M+
  • Earnings buffer: 7 days

Holding period: 1-4 weeks | Risk level: Medium-High

📊 Signals (2 of 2)

Ranked by composite momentum score

# Ticker Company Sector Price Score Insider MCap
1 HAFN Hafnia Limited Industrials $9.67 0.30 — $4.8B
2 MGNI Magnite, Inc. Communication Services $25.67 0.00 — $3.7B

Quality Low Vol

High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.

Entry Criteria:

  • Strong RSI momentum (configurable thresholds)
  • Volume surge above average
  • Price momentum confirmation
  • Minimum ADV: $25M+ (varies by variant)
  • Earnings buffer: 7 days pre/post earnings
  • Variant-specific filters applied

Holding period: 1-4 weeks | Risk level: Medium-High

📊 Signals (1 of 1)

Ranked by composite momentum score (higher = stronger momentum)

# Ticker Company Sector Price Score Insider MCap
1 GMAB Genmab A/S Healthcare $35.57 0.00 — $21.8B

Cap Large Only

High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.

Entry Criteria:

  • Strong RSI momentum (configurable thresholds)
  • Volume surge above average
  • Price momentum confirmation
  • Minimum ADV: $25M+ (varies by variant)
  • Earnings buffer: 7 days pre/post earnings
  • Variant-specific filters applied

Holding period: 1-4 weeks | Risk level: Medium-High

📊 Signals (1 of 1)

Ranked by composite momentum score (higher = stronger momentum)

# Ticker Company Sector Price Score Insider MCap
1 GMAB Genmab A/S Healthcare $35.57 0.00 — $21.8B

Breakout Ultra Tight

High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.

Entry Criteria:

  • Strong RSI momentum (configurable thresholds)
  • Volume surge above average
  • Price momentum confirmation
  • Minimum ADV: $25M+ (varies by variant)
  • Earnings buffer: 7 days pre/post earnings
  • Variant-specific filters applied

Holding period: 1-4 weeks | Risk level: Medium-High

📊 Signals (1 of 1)

Ranked by composite momentum score (higher = stronger momentum)

# Ticker Company Sector Price Score Insider MCap
1 ITGR Integer Holdings Corpo... Healthcare $126.33 0.00 — $4.3B

Field Notes

Sector concentration: Healthcare (10), Communication Services (2), Consumer Defensive (1)

Insider selling (7d): TWST (Twist Bioscience Corporation, -$15,322)

Data coverage: 7.1% insider (7d), 0.0% congressional (30d), 0.0% earnings, 21.4% news (7d)

Vlad's Take

Today's signals: Strong sector concentration in Healthcare (10 signals) suggests sector-specific rotation.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.